Cargando…
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development
OBJECTIVE AND BACKGROUND: The clinical trials community has been hesitant to adopt Bayesian statistical methods, which are often more flexible and efficient with more naturally interpretable results than frequentist methods. We aimed to identify self-reported barriers to implementing Bayesian method...
Autores principales: | Clark, Jennifer, Muhlemann, Natalia, Natanegara, Fanni, Hartley, Andrew, Wenkert, Deborah, Wang, Fei, Harrell, Frank E., Bray, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720547/ https://www.ncbi.nlm.nih.gov/pubmed/34978048 http://dx.doi.org/10.1007/s43441-021-00357-x |
Ejemplares similares
-
Leveraging Patient Preference Information in Medical Device Clinical Trial Design
por: Rincon-Gonzalez, Liliana, et al.
Publicado: (2022) -
What’s more general than a whole population?
por: Alexander, Neal
Publicado: (2015) -
Causal criteria and counterfactuals; nothing more (or less) than scientific common sense
por: Phillips, Carl V, et al.
Publicado: (2006) -
Applied Research in Low-Income Countries: Why and How?
por: Acharya, Krishna Prasad, et al.
Publicado: (2019) -
What's trust got to do with research: why not accountability?
por: Foláyan, Morẹ́nikẹ́ Oluwátóyìn, et al.
Publicado: (2023)